Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
-
* Corresponding author: Ivette F Emery emeryi@mccm.org
BMC Cancer 2009, 9:333 doi:10.1186/1471-2407-9-333
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 12 Feb 2009 | |
| Reviewer's Report | Sophie Barillé-Nion | 17 Apr 2009 | |
| Reviewer's Report | Jaafar Bennouna | 24 Apr 2009 | |
| Reviewer's Report | Olivier Coqueret | 11 May 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 08 Jun 2009 |
| Reviewer's Report | Sophie Barillé-Nion | 11 Jun 2009 | |
| Reviewer's Report | Olivier Coqueret | 01 Jul 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 20 Jul 2009 |
| Resubmission - Version 4 | Manuscript | Author's comment | 30 Jul 2009 |
| Resubmission - Version 5 | Manuscript | Author's comment | 06 Aug 2009 |
| Resubmission - Version 6 | Manuscript | Author's comment | 08 Sep 2009 |
| Editorial acceptance | 15 Sep 2009 | ||
| Published | 18 Sep 2009 |